Befejeződött1. fázis
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants with Systemic Lupus Erythematosus
Key facts
- Where
- Bydgoszcz és Poznan, LengyelországSee the 2 sites
- Phase
- 1. fázis
Where in Lengyelország
- Szpital Uniwersytecki nr 2 im dr Jana Biziela w BydgoszczyBydgoszcz, LengyelországNo longer taking part
- Uniwersytecki Szpital Kliniczny w PoznaniuPoznan, LengyelországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2023-509188-26-00
- Record updated
- 2025. február 10.